{"id":"https://openalex.org/W33372576","doi":null,"title":"Anti-annexin V antibodies and digital ischemia in patients with scleroderma.","display_name":"Anti-annexin V antibodies and digital ischemia in patients with scleroderma.","publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W33372576","mag":"33372576","pmid":"https://pubmed.ncbi.nlm.nih.gov/10529134"},"language":"en","primary_location":{"id":"pmid:10529134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10529134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114022615","display_name":"K Sugiura","orcid":"https://orcid.org/0000-0003-3414-0434","observed_orcids":["https://orcid.org/0000-0003-3414-0434"]},"institutions":[{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Sugiura","raw_affiliation_strings":["Department of Dermatology, Nagoya University School of Medicine, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Nagoya University School of Medicine, Japan","institution_ids":["https://openalex.org/I4210090647","https://openalex.org/I60134161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083759000","display_name":"Yoshinao Muro","orcid":"https://orcid.org/0000-0003-2329-8375","observed_orcids":["https://orcid.org/0000-0003-2329-8375"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Muro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4158,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.57404902,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"26","issue":"10","first_page":"2168","last_page":"72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-annexin-v-antibodies","display_name":"anti-annexin V antibodies","score":0.9869999885559082},{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/digital-ischemia","display_name":"digital ischemia","score":0.890999972820282},{"id":"https://openalex.org/keywords/igg-autoantibodies","display_name":"IgG autoantibodies","score":0.7390000224113464},{"id":"https://openalex.org/keywords/anticardiolipin-antibodies","display_name":"anticardiolipin antibodies","score":0.9580000042915344},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9700000286102295},{"id":"https://openalex.org/keywords/vascular-involvement","display_name":"vascular involvement","score":0.8600000143051147},{"id":"https://openalex.org/keywords/autoantibody-prevalence","display_name":"autoantibody prevalence","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.860231876373291},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.729383111000061},{"id":"https://openalex.org/C2779967694","wikidata":"https://www.wikidata.org/wiki/Q1383511","display_name":"Scleroderma (fungus)","level":3,"score":0.7224472761154175},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.6218589544296265},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.49574264883995056},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.45267558097839355},{"id":"https://openalex.org/C2778674544","wikidata":"https://www.wikidata.org/wiki/Q1414805","display_name":"Systemic disease","level":3,"score":0.4507071375846863},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.43953800201416016},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4371377229690552},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.43482571840286255},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.40285730361938477},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.3117183446884155},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.2528276741504669},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.08583700656890869},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.0679582953453064},{"id":"https://openalex.org/C180032290","wikidata":"https://www.wikidata.org/wiki/Q1664296","display_name":"Inoculation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005385","descriptor_name":"Fingers","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007075","descriptor_name":"Immunoglobulin M","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007511","descriptor_name":"Ischemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D007511","descriptor_name":"Ischemia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007511","descriptor_name":"Ischemia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010314","descriptor_name":"Partial Thromboplastin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017304","descriptor_name":"Annexin A5","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10529134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10529134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Journal Article"},{"id":"mag:33372576","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10529134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W4247665917","https://openalex.org/W2751563067","https://openalex.org/W2027105013","https://openalex.org/W2044099053","https://openalex.org/W2121803961","https://openalex.org/W2141515175","https://openalex.org/W2119279206","https://openalex.org/W2142823391","https://openalex.org/W2016521818","https://openalex.org/W1594303435","https://openalex.org/W2462570828","https://openalex.org/W2142415528","https://openalex.org/W2200374642","https://openalex.org/W2943610538","https://openalex.org/W2092813632","https://openalex.org/W1967608745","https://openalex.org/W2335782101","https://openalex.org/W2151582777","https://openalex.org/W2166079243","https://openalex.org/W1991945936","https://openalex.org/W2109813510","https://openalex.org/W2996043226","https://openalex.org/W2003220763","https://openalex.org/W1510105321","https://openalex.org/W2017283051","https://openalex.org/W2151757477","https://openalex.org/W2027527663","https://openalex.org/W2980977042","https://openalex.org/W2049078130","https://openalex.org/W3033675355","https://openalex.org/W2132322340","https://openalex.org/W1972774304","https://openalex.org/W2054287930","https://openalex.org/W2790314287","https://openalex.org/W1987375729","https://openalex.org/W2430453425","https://openalex.org/W2035780279","https://openalex.org/W2938853639","https://openalex.org/W2155873686","https://openalex.org/W2777828834","https://openalex.org/W3041502789","https://openalex.org/W2060023498","https://openalex.org/W2090287582","https://openalex.org/W2071669554","https://openalex.org/W2028900007","https://openalex.org/W1966288658","https://openalex.org/W1953106989","https://openalex.org/W2938966007","https://openalex.org/W1991631106","https://openalex.org/W2104552834","https://openalex.org/W2167485140","https://openalex.org/W1847575571","https://openalex.org/W2120718308","https://openalex.org/W2334681029","https://openalex.org/W2105476520","https://openalex.org/W1990833592","https://openalex.org/W2043705607","https://openalex.org/W2802124756","https://openalex.org/W1973597822","https://openalex.org/W2578303353","https://openalex.org/W2153113149","https://openalex.org/W2789905820","https://openalex.org/W2885142638"],"related_works":["https://openalex.org/W2417686440","https://openalex.org/W87433825","https://openalex.org/W2418734455","https://openalex.org/W2062755612","https://openalex.org/W3046814417","https://openalex.org/W2489601078","https://openalex.org/W2524145851","https://openalex.org/W2342387071","https://openalex.org/W2037339637","https://openalex.org/W2047285663"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"elucidate":[2],"the":[3,63,71,122],"frequency":[4],"and":[5,37],"clinical":[6],"significance":[7],"of":[8,21,70,124],"anti-annexin":[9,32,41,80,98],"V":[10,33,42,55,81,99,107],"antibodies":[11,34,43,56,82,100,108,117],"in":[12,48,62,109,127],"patients":[13,23,50,64,78],"with":[14,24,52,59,65,79,121],"scleroderma.":[15,25,53,66,128],"METHODS:":[16],"The":[17],"study":[18],"population":[19],"consisted":[20],"66":[22],"Their":[26],"sera":[27],"were":[28,44,57,83,101],"examined":[29,85],"for":[30,86],"IgG":[31,40,97],"by":[35,46,103],"ELISA":[36,47],"immunoblotting.":[38,104],"RESULTS:":[39],"detected":[45,102],"12":[49,72],"(18.2%)":[51],"Anti-annexin":[54,106],"associated":[58,120],"digital":[60,114],"ischemia":[61],"Only":[67],"one":[68],"patient":[69],"had":[73],"anticardiolipin":[74],"antibodies.":[75],"Although":[76],"6":[77],"also":[84],"activated":[87],"partial":[88],"thromboplastin":[89],"time":[90],"(APTT),":[91],"none":[92],"showed":[93],"prolonged":[94],"APTT.":[95],"No":[96],"CONCLUSION:":[105],"scleroderma":[110],"are":[111],"related":[112],"to":[113],"ischemia.":[115],"These":[116],"may":[118],"be":[119],"pathogenesis":[123],"vascular":[125],"involvement":[126]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}